Clinically and Microbiologically Derived Azithromycin Susceptibility Breakpoints for Salmonella enterica Serovars Typhi and Paratyphi A

Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Christopher M., Thieu, Nga Tran Vu, Dolecek, Christiane, Karkey, Abhilasha, Gupta, Ruchi, Turner, Paul, Dance, David, Maude, Rapeephan R., Ha, Vinh, Tran, Chinh Nguyen, Thi, Phuong Le, Be, Bay Pham Van, Phi, La Tran Thi, Ngoc, Rang Nguyen, Ghose, Aniruddha, Dongol, Sabina, Campbell, James I., Thanh, Duy Pham, Thanh, Tuyen Ha, Moore, Catrin E., Sona, Soeng, Gaind, Rajni, Deb, Monorama, Anh, Ho Van, Van, Sach Nguyen, Tinh, Hien Tran, Day, Nicholas P. J., Dondorp, Arjen, Thwaites, Guy, Faiz, Mohamed Abul, Phetsouvanh, Rattanaphone, Newton, Paul, Basnyat, Buddha, Farrar, Jeremy J., Baker, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2015
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394775/
https://www.ncbi.nlm.nih.gov/pubmed/25733500
http://dx.doi.org/10.1128/AAC.04729-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394775/
https://www.ncbi.nlm.nih.gov/pubmed/25733500
http://dx.doi.org/10.1128/AAC.04729-14

Ejemplares similares